Damon Runyon-Rachleff Innovation Award:
The Damon Runyon-Rachleff Innovation Award supports the next generation of exceptionally creative thinkers with “high-risk/high-reward” ideas that have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis or treatment of cancer but lack sufficient preliminary data to obtain traditional funding
Application Deadline: July 6, 2018
- Fund: The Stage 1 award will be for two years, $150,000 per year ($300,000 total) with the opportunity for up to two additional years of funding (up to four years total for $600,000). Stage 2 support for years three and four will be granted to those awardees who demonstrate progress on their proposed research during years one and two of the award. Applicants will provide a written update on their research and present their progress in person to the committee shortly before the end of the second year of the award, at which time the committee will make a decision regarding continued funding.
- Application guidelines: https://www.damonrunyon.org/for-scientists/application-guidelines/innovation/forms
- Eligibility: https://www.damonrunyon.org/for-scientists/application-guidelines/innovation#eligibility
Damon Runyon Dale F. Frey Award for Breakthrough Scientists
There are often a select few Damon Runyon and Damon Runyon-Sohn Fellows who have greatly exceeded the Foundation’s highest expectations. To catapult their research careers, the Foundation will make an additional investment in these exceptional individuals at the end of the Fellowship by selecting them as recipients of the Damon Runyon Dale F. Frey Award for Breakthrough Scientists.
- The award is $100,000 paid over one year and must be expended within two years of the initial award date.
- Application deadline: July 16, 2018
- Application guideline: https://www.damonrunyon.org/for-scientists/application-guidelines/breakthrough/forms
Leukemia and Lymphoma Society Translational Research Program and The Career Development Program
The Translational Research Program:
TRP puts you on the bench-to-bedside fast track when it comes to finding better treatment and cures for leukemia, lymphoma and myeloma. The Leukemia & Lymphoma Society funds new and innovative research that shows high promise for translating basic biomedical knowledge to clinical application.
- Award: Limited to a maximum of $200,000, which includes direct costs and a maximum overhead of $19,982 or 11.1 percent of direct costs per year for three years.
- Letter of Intent Phase Opens May 1, 2018
- Letter of Intent Due August 31, 2018, 3:00 PM (ET)
- Full Application Due October 31, 2018, 3:00 PM (ET)
Career Development Program - Award Categories
- Scholar : Award: $110,000 per year for five years
- Guidelines and eligibility
Scholar in Clinical Research : Award: $125,000 per year for five years
New this year: Eligibility is expanded to include any permanent, independent clinical faculty who are not on a laboratory-based, tenure-track career path. The research support requirement is expanded to include funding from any source that adequately supports the research. Protected time for research is now defined to be in the range of 20-40%. The award amount is increased to $125,000/year. Some of the award may be used for salaries of other personnel who are directly connected with the clinical research activities of the applicant.
- Eligibility Phase Open May 1, 2018
- Eligibility Determination by LLS Staff May 18 - September 7, 2018 ; Eligibility Due August 31, 2018, 3:00 PM (ET)
- Abstract Phase Open After eligibility is approved ; Abstracts Due September 14, 2018, 3:00 PM (ET)
- Reference Letters Due October 2, 2018, 3:00 PM (ET)
- Full Applications Due October 2, 2018, 3:00 PM (ET)
Visit this e-grantmaking website shared by many government, non-profit, and private grant-making organizations, and search for a grant that fits your needs.
AACR - Research Funding Opportunities
The AACR is currently accepting applications for fellowships in translational immuno-oncology, research on the HER Family Pathway, translational or clinical sarcoma research, and for a career development award for angiogenesis research.